{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:28:19Z","timestamp":1764174499502,"version":"3.37.3"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005258","name":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention","doi-asserted-by":"publisher","award":["5U1B\/PS003252"],"award-info":[{"award-number":["5U1B\/PS003252"]}],"id":[{"id":"10.13039\/100005258","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196157","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T13:27:32Z","timestamp":1524835652000},"page":"e0196157","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Knowledge of hepatitis C status moderates the relationship between history of drug treatment and sterile syringe use"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5045-7944","authenticated-orcid":true,"given":"Kiva Ariani","family":"Fisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Michele","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Broyles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Rorke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Thomas","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/tmi.12465","article-title":"Prevalence of hepatitis C virus in mothers and their children in Malawi","volume":"20","author":"JM Fox","year":"2015","journal-title":"Tropical Medicine & International Health"},{"journal-title":"Hepatitis C FAQs for Health Professionals: Transmission and Symptoms","article-title":"Hepatitis C FAQs for Health Professionals: Transmission and Symptoms","year":"2015","key":"ref2"},{"issue":"45","key":"ref3","first-page":"1488","article-title":"Syringe exchange programs\u2014United States, 2008","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.15288\/jsad.2009.70.516","article-title":"Cognitive-Behavioral treatment with adult alcohol and illicit drug users: A Meta-Analysis of randomized controlled trials","volume":"70","author":"M Magill","year":"2009","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"L. Dutra","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"ref6","unstructured":"National Institutes of Drug Abuse. Principles of drug addiction treatment: A research-based guide (Third Edition). Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drugabuse.gov\/publications\/principles-drug-addiction-treatment-research-based-guide-third-edition\" xlink:type=\"simple\">https:\/\/www.drugabuse.gov\/publications\/principles-drug-addiction-treatment-research-based-guide-third-edition<\/ext-link>. Accessed 02\/13, 2017."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e5945","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"GJ MacArthur","year":"2012","journal-title":"BMJ"},{"key":"ref8","first-page":"345","article-title":"The impact and cost-effectiveness of methadone maintenance treatment in preventing HIV and hepatitis C","author":"H Pollack","year":"2004","journal-title":"Monographs"},{"year":"2012","author":"JC Ball","key":"ref9"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1046\/j.1360-0443.2002.00208.x","article-title":"The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users","volume":"97","author":"CF Kwiatkowski","year":"2002","journal-title":"Addiction"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.drugalcdep.2009.07.005","article-title":"Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users","volume":"105","author":"RD Burt","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/infdis\/jit520","article-title":"&quot;To share or not to share?&quot; Serosorting by hepatitis C status in the sharing of drug injection equipment among NHBS-IDU2 participants","volume":"208","author":"BD Smith","year":"2013","journal-title":"J Infect Dis"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/003335490612100611","article-title":"Self-reported hepatitis C virus antibody status and risk behavior in young injectors","volume":"121","author":"H Hagan","year":"2006","journal-title":"Public Health Rep"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.addbeh.2011.12.001","article-title":"Injection behaviors among injection drug users in treatment: the role of hepatitis C awareness","volume":"37","author":"PT Korthuis","year":"2012","journal-title":"Addict Behav"},{"issue":"4","key":"ref15","first-page":"548","article-title":"Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users","volume":"44","author":"J Cox","year":"2009"},{"issue":"Suppl 1","key":"ref16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/00333549071220S106","article-title":"Behavioral surveillance among people at risk for HIV infection in the U.S.: the National HIV Behavioral Surveillance System","volume":"122","author":"KM Gallagher","year":"2007","journal-title":"Public Health Rep"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/3096941","article-title":"Respondent-driven sampling: a new approach to the study of hidden populations","author":"DD Heckathorn","year":"1997","journal-title":"Soc Probl"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.0081-1750.2004.00152.x","article-title":"Sampling and estimation in hidden populations using respondent-driven sampling","volume":"34","author":"MJ Salganik","year":"2004","journal-title":"Sociological methodology"},{"journal-title":"National HIV Behavioral Surveillance Round 4: Model Surveillance Protocol","article-title":"National HIV Behavioral Surveillance Round 4: Model Surveillance Protocol","year":"2014","key":"ref19"},{"key":"ref20","first-page":"9","article-title":"A prospective study to investigate predictors of relapse among patients with opioid use disorder treated with methadone","volume":"10","author":"L Naji","year":"2016","journal-title":"Substance Abuse: Research and Treatment"},{"key":"ref21","unstructured":"NIDA. Principles of Drug Addiction Treatment: A Research-Based Guide (Third Edition). National Institute on Drug Abuse website. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drugabuse.gov\/publications\/principles-drug-addiction-treatment-research-based-guide-third-edition\" xlink:type=\"simple\">https:\/\/www.drugabuse.gov\/publications\/principles-drug-addiction-treatment-research-based-guide-third-edition<\/ext-link>. January 17, 2018. Accessed March 29, 2018."},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10461-010-9751-7","article-title":"Reducing HIV-Related Risk Behaviors Among Injection Drug Users in Residential Detoxification","volume":"15","author":"RE Booth","year":"2011","journal-title":"AIDS & Behavior"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"e0135901","DOI":"10.1371\/journal.pone.0135901","article-title":"Mathematical modeling of hepatitis C prevalence reduction with antiviral treatment scale-up in persons who inject drugs in metropolitan Chicago","volume":"10","author":"D Echevarria","year":"2015","journal-title":"PloS one"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"NK Martin","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/add.13521","article-title":"Hepatitis C virus prevention and treatment prioritization\u2014ethical, economic and evidential dimensions of early rather than delayed treatment for people who inject drugs","volume":"112","author":"M Hickman","year":"2017","journal-title":"Addiction"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/cid\/cit301","article-title":"Hepatitis C virus reinfection following treatment among people who use drugs","volume":"57","author":"BP Grady","year":"2013","journal-title":"Clinical infectious diseases"},{"article-title":"Survey methodology","year":"2011","author":"RM Groves","key":"ref27"},{"issue":"12","key":"ref28","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"JI Tsui","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"8","key":"ref29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jech-2014-205224","article-title":"A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs","volume":"69","author":"T Spelman","year":"2015","journal-title":"J Epidemiol Community Health"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:10:16Z","timestamp":1540343416000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196157"}},"subtitle":[],"editor":[{"given":"Georgios \u039a","family":"Nikolopoulos","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196157","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}